Background Although recent epidemiological data suggest that pneumococci may contribute
to the risk of SARS-CoV-2 disease, cases of coinfection with Streptococcus pneumoniae in …

Background Streptococcus pneumoniae interacts with numerous viral respiratory pathogens
in the upper airway. It is unclear whether similar interactions occur with severe acute …

Research conducted on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pathogenesis and coronavirus disease 2019 (COVID-19) generally focuses on the systemic …

Background Past respiratory viral epidemics suggest that bacterial infections impact clinical
outcomes. There is minimal information on potential co-pathogens in patients with …

Background Streptococcus pneumoniae coinfection with influenza results in synergistic
lethality, but there are limited data on pneumococcal coinfection with severe acute …

Objectives SARS-CoV-2 may cause acute lung injury, and secondary infections are thus
relevant complications in patients with COVID-19 pneumonia. However, detailed information …

Secondary bacterial infections enhance the disease burden of influenza infections
substantially. Streptococcus pneumoniae (the pneumococcus) plays a major role in the …

Secondary bacterial infections, including ventilator-associated pneumonia (VAP), lead to
worse clinical outcomes and increased mortality following viral respiratory infections …

Emerging evidence indicates that severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2)-infected individuals are at an increased risk for coinfections; therefore, physicians …

The seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was
examined among 105 healthcare workers (HCWs) exposed to four patients who were …